Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Ryan Clauson, M.D.
Family Practice · BISMARCK, ND · NPI 1629230081
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 518 | 137 |
| Levothyroxine Sodium | Levothyroxine Sodium | 375 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 328 | 84 |
| Lisinopril | Lisinopril | 324 | 87 |
| Omeprazole | Omeprazole | 274 | 79 |
| Losartan Potassium | Losartan Potassium | 269 | 69 |
| Hydrochlorothiazide | Hydrochlorothiazide | 232 | 67 |
| Eliquis | Apixaban | 195 | 42 |
| Furosemide | Furosemide | 185 | 43 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 185 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 182 | 49 |
| Gabapentin | Gabapentin | 147 | 35 |
| Allopurinol | Allopurinol | 146 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 146 | 39 |
| Sertraline Hcl | Sertraline Hcl | 141 | 37 |
| Metformin Hcl | Metformin Hcl | 138 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 130 | 38 |
| Famotidine | Famotidine | 123 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 119 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 117 | 26 |
| Trazodone Hcl | Trazodone Hcl | 105 | 21 |
| Simvastatin | Simvastatin | 102 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 97 | 25 |
| Metformin Hcl Er | Metformin Hcl | 97 | 27 |
| Ozempic | Semaglutide | 94 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 87 | 22 |
| Lorazepam | Lorazepam | 80 | 27 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 75 | suppressed |
| Potassium Chloride | Potassium Chloride | 74 | 19 |
| Jardiance | Empagliflozin | 67 | 13 |
| Tramadol Hcl | Tramadol Hcl | 67 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 64 | 34 |
| Meloxicam | Meloxicam | 64 | 19 |
| Alendronate Sodium | Alendronate Sodium | 62 | 13 |
| Atenolol | Atenolol | 60 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 58 | 48 |
| Pregabalin | Pregabalin | 57 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 53 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 50 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 48 | suppressed |
| Synthroid | Levothyroxine Sodium | 48 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 48 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 47 | 17 |
| Glipizide Er | Glipizide | 46 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | 12 |
| Bupropion Xl | Bupropion Hcl | 44 | suppressed |
| Baclofen | Baclofen | 43 | suppressed |
| Carvedilol | Carvedilol | 42 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 42 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 41 | suppressed |
| Clonazepam | Clonazepam | 40 | suppressed |
| Finasteride | Finasteride | 40 | suppressed |
| Celecoxib | Celecoxib | 39 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 39 | 13 |
| Ezetimibe | Ezetimibe | 36 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 23 |
| Glipizide | Glipizide | 34 | suppressed |
| Prednisone | Prednisone | 34 | 27 |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Cephalexin | Cephalexin | 31 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 31 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Oxycontin | Oxycodone Hcl | 31 | suppressed |
| Spironolactone | Spironolactone | 30 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 28 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 26 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 26 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 26 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 22 |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Mirtazapine | Mirtazapine | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 22 | suppressed |
| Ramipril | Ramipril | 22 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 17 |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 19 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 15 | suppressed |
| Felodipine Er | Felodipine | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Januvia | Sitagliptin Phosphate | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | 11 |
| Glimepiride | Glimepiride | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
| Xarelto | Rivaroxaban | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error